284 related articles for article (PubMed ID: 22351662)
1. The activity of 16 new hydantoin compounds on the intrinsic and overexpressed efflux pump system of Staphylococcus aureus.
Dymek A; Armada A; Handzlik J; Viveiros M; Spengler G; Molnar J; Kieć-Kononowicz K; Amaral L
In Vivo; 2012; 26(2):223-9. PubMed ID: 22351662
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of forty new phenothiazine derivatives for activity against intrinsic efflux pump systems of reference Escherichia coli, Salmonella Enteritidis, Enterococcus faecalis and Staphylococcus aureus strains.
Takács D; Cerca P; Martins A; Riedl Z; Hajós G; Molnár J; Viveiros M; Couto I; Amaral L
In Vivo; 2011; 25(5):719-24. PubMed ID: 21753124
[TBL] [Abstract][Full Text] [Related]
3. Prolonged exposure of methicillin-resistant Staphylococcus aureus (MRSA) COL strain to increasing concentrations of oxacillin results in a multidrug-resistant phenotype.
Martins A; Couto I; Aagaard L; Martins M; Viveiros M; Kristiansen JE; Amaral L
Int J Antimicrob Agents; 2007 Mar; 29(3):302-5. PubMed ID: 17276037
[TBL] [Abstract][Full Text] [Related]
4. Biological activity of twenty-three hydantoin derivatives on intrinsic efflux pump system of Salmonella enterica serovar Enteritidis NCTC 13349.
Machado L; Spengler G; Evaristo M; Handzlik J; Molnár J; Viveiros M; Kiec-Kononowicz K; Amaral L
In Vivo; 2011; 25(5):769-72. PubMed ID: 21753132
[TBL] [Abstract][Full Text] [Related]
5. Efflux-mediated response of Staphylococcus aureus exposed to ethidium bromide.
Couto I; Costa SS; Viveiros M; Martins M; Amaral L
J Antimicrob Chemother; 2008 Sep; 62(3):504-13. PubMed ID: 18511413
[TBL] [Abstract][Full Text] [Related]
6. Screening for efflux pump systems of bacteria by the new acridine orange agar method.
Martins A; Amaral L
In Vivo; 2012; 26(2):203-6. PubMed ID: 22351659
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of quorum sensing and efflux pump system by trifluoromethyl ketone proton pump inhibitors.
Varga ZG; Armada A; Cerca P; Amaral L; Mior Ahmad Subki MA; Savka MA; Szegedi E; Kawase M; Motohashi N; Molnár J
In Vivo; 2012; 26(2):277-85. PubMed ID: 22351670
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of efflux pumps in methicillin-resistant Staphylococcus aureus and Enterococcus faecalis resistant strains by triterpenoids from Momordica balsamina.
Ramalhete C; Spengler G; Martins A; Martins M; Viveiros M; Mulhovo S; Ferreira MJ; Amaral L
Int J Antimicrob Agents; 2011 Jan; 37(1):70-4. PubMed ID: 21075604
[TBL] [Abstract][Full Text] [Related]
9. Thioridazine reduces resistance of methicillin-resistant staphylococcus aureus by inhibiting a reserpine-sensitive efflux pump.
Kristiansen MM; Leandro C; Ordway D; Martins M; Viveiros M; Pacheco T; Molnar J; Kristiansen JE; Amaral L
In Vivo; 2006; 20(3):361-6. PubMed ID: 16724671
[TBL] [Abstract][Full Text] [Related]
10. From phenothiazine to 3-phenyl-1,4-benzothiazine derivatives as inhibitors of the Staphylococcus aureus NorA multidrug efflux pump.
Sabatini S; Kaatz GW; Rossolini GM; Brandini D; Fravolini A
J Med Chem; 2008 Jul; 51(14):4321-30. PubMed ID: 18578473
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic and genotypic characterisation of multiple antibiotic-resistant Staphylococcus aureus exposed to subinhibitory levels of oxacillin and levofloxacin.
Jo A; Ahn J
BMC Microbiol; 2016 Jul; 16(1):170. PubMed ID: 27473500
[TBL] [Abstract][Full Text] [Related]
12. Re-evolution of the 2-phenylquinolines: ligand-based design, synthesis, and biological evaluation of a potent new class of Staphylococcus aureus NorA efflux pump inhibitors to combat antimicrobial resistance.
Sabatini S; Gosetto F; Iraci N; Barreca ML; Massari S; Sancineto L; Manfroni G; Tabarrini O; Dimovska M; Kaatz GW; Cecchetti V
J Med Chem; 2013 Jun; 56(12):4975-89. PubMed ID: 23710549
[TBL] [Abstract][Full Text] [Related]
13. Amine-alkyl derivatives of hydantoin: new tool to combat resistant bacteria.
Handzlik J; Szymańska E; Chevalier J; Otrębska E; Kieć-Kononowicz K; Pagès JM; Alibert S
Eur J Med Chem; 2011 Dec; 46(12):5807-16. PubMed ID: 22000919
[TBL] [Abstract][Full Text] [Related]
14. [Efflux pumps: their role in Staphylococcus aureus antibiotic resistance].
Doléans-Jordheim A; Michalet S; Bergeron E; Boisset S; Souard F; Dumontet C; Dijoux-Franca MG; Freney J
Ann Biol Clin (Paris); 2008; 66(5):499-508. PubMed ID: 18957338
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
Chan BC; Ip M; Lau CB; Lui SL; Jolivalt C; Ganem-Elbaz C; Litaudon M; Reiner NE; Gong H; See RH; Fung KP; Leung PC
J Ethnopharmacol; 2011 Sep; 137(1):767-73. PubMed ID: 21782012
[TBL] [Abstract][Full Text] [Related]
16. Chalcone inhibitors of the NorA efflux pump in Staphylococcus aureus whole cells and enriched everted membrane vesicles.
Holler JG; Slotved HC; Mølgaard P; Olsen CE; Christensen SB
Bioorg Med Chem; 2012 Jul; 20(14):4514-21. PubMed ID: 22682300
[TBL] [Abstract][Full Text] [Related]
17. Activity of fourteen new hydantoin compounds on the human ABCB1 efflux pump.
Martins A; Dymek A; Handzlik J; Spengler G; Armada A; Molnar J; Kiéc-Kononowicz K; Amaral L
In Vivo; 2012; 26(2):293-7. PubMed ID: 22351672
[TBL] [Abstract][Full Text] [Related]
18. Effect of overexpression of small non-coding DsrA RNA on multidrug efflux in Escherichia coli.
Nishino K; Yamasaki S; Hayashi-Nishino M; Yamaguchi A
J Antimicrob Chemother; 2011 Feb; 66(2):291-6. PubMed ID: 21088020
[TBL] [Abstract][Full Text] [Related]
19. NorA efflux pump inhibitory activity of coumarins from Mesua ferrea.
Roy SK; Kumari N; Pahwa S; Agrahari UC; Bhutani KK; Jachak SM; Nandanwar H
Fitoterapia; 2013 Oct; 90():140-50. PubMed ID: 23892000
[TBL] [Abstract][Full Text] [Related]
20. Structural differences between paroxetine and femoxetine responsible for differential inhibition of Staphylococcus aureus efflux pumps.
Wei P; Kaatz GW; Kerns RJ
Bioorg Med Chem Lett; 2004 Jun; 14(12):3093-7. PubMed ID: 15149651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
